Table 1. General characteristics.

	Transwomen			Transmen
	N	%		N	%			p
Total	82			72
	Mean	SD			Mean	SD
Age	42.4	12.4			32.4	11.2		< 0.001
BMI	24.6	3.9			25.1	4.5		n.s.
	N	%		N	%
Hormone treatment
Yes	65	79.3		58	80.6			n.s.
No	17	20.7		14	19.4
Estradiol
Gel	21	30.8		NA
Tablets	21	30.8		NA
Patches	24	36.9		NA
Tablets + Gel		1.5		NA
Cyproterone acetate		46.2		NA
Testosterone
Gel	NA			26	44.8
Enanthate injections	NA			15	25.9
Undecanoate injections	NA			14	24.1
Not documented	NA			3	5.2
	Mean	SD			Mean	SD
Time since start of hormone therapy (months)	26	6	173		18	6	245	n.s.
Living alone	N	%		N	%
Yes	51	62.2		42	58.3			n.s.
No	30	36.6		29	40.3
Missing	1	1.2		1	1.4
Education
No graduation	4	4.9		0	0.0			n.s.
Low	19	23.2		16	22.2
Intermediate	29	35.4		38	52.8
High	13	15.9		6	8.3
University	16	19.5		12	16.7
Missing	1	1.2		0	0.0
Unemployed
Employed	74.0	90.2		67	93.1			n.s.
Unemployed	8.0	9.8		5	6.9
Estimated financial situation
Good	42.0	51.2		35	48.6			n.s.
Average	13.0	15.9		9	12.5
Bad	26.0	31.7		27	37.5
Missing	1.0	1.2		1	1.4
Age of onset
Early	62.0	75.6		62	86.1			n.s.
Late	20.0	24.4		9	12.5
Missing	0.0	0.0		1	1.4
Surgeries
Mastectomy
Yes	NA			31	43.1
No	NA			41	56.9
Any genital surgery								n.s.
Yes	25.0	30.5		20	27.8
No	57.0	69.5		52	72.2
Penoid
Yes	NA			8	11.1
No	NA			64	88.9
Breast augmentation
Yes	14	17.1		NA
No	68	82.9		NA

Comparisons were done by students’ T-test for continuous variables and X² or Fishers exact test for categorical variables

Bold numbers indicate significant differences

NA: not applicable

n.s.: not significant